FDA could soon approve a nasal spray to treat depression - WSLS 10

FDA could soon approve a nasal spray to treat depression  WSLS 10The FDA is on the brink of approving a breakthrough depression drug. Johnson & Johnson's esketamine is a fast-acting antidepressant administered by a nasal ...